Related Experiment Video
Updated: Jul 20, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
The Biggest Unmet Needs in Cardiovascular Disease Prevention in 2023
1Professor of Cardiovascular Medicine, Trinity College Dublin, Dublin, Ireland.
Insights
Effective cardiovascular disease (CVD) prevention requires addressing societal and political challenges beyond new medications. Empowering individuals to understand risk and promoting integrated strategies are crucial for better public health outcomes.
Area of Science:
- Cardiology
- Public Health
- Health Policy
Background:
- Despite known causes of atherosclerotic cardiovascular disease (CVD), clinical audits reveal persistent inadequate risk factor control, particularly in high-risk individuals.
- Current guidelines for CVD prevention, though comprehensive, may be underutilized due to their length and complexity.
- Factors hindering the effective implementation of CVD prevention guidelines are examined.
Purpose of the Study:
- To outline advances in cardiovascular disease (CVD) risk estimation methods.
- To explore barriers to the implementation of existing CVD prevention guidelines.
- To highlight the societal and political factors critical for effective CVD prevention.
Main Methods:
- Review of current advances in CVD risk estimation.
- Analysis of factors inhibiting guideline implementation.
- Exploration of societal and political determinants of CVD prevention.
Main Results:
- New medications are being developed, but societal and political issues pose the primary obstacles to effective CVD prevention.
- There is a need for cohesive, integrated strategies at national and European levels with clear responsibilities and accountability.
- Addressing profound health inequalities is essential for equitable CVD prevention.
Conclusions:
- Effective cardiovascular disease (CVD) prevention necessitates integrated societal and political strategies, not solely medical advancements.
- Empowering individuals with knowledge about risk and self-management is vital.
- Tackling health inequalities is a fundamental requirement for improving CVD prevention outcomes.
Background:
While the major causes of atherosclerotic cardiovascular disease (CVD) are known, clinical audits continue to show inadequate risk factor control, even in the highest risk subjects. More effective risk estimation methods may help, and advances in this field are outlined. There exist excellent guidelines on CVD prevention, but their very length and complexity may limit their use. Other factors inhibiting guideline implementation are explored.
Summary:
While new medications continue to be developed, the real challenges to effective CVD prevention are societal and political. Both nationally and at European levels, cohesive, integrated strategies with defined responsibilities and accountability are needed, together with empowerment of people to understand the concept of risk and what they can do about it.
Key Messages:
There are profound health inequalities between and within countries that need to be addressed.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Cardiomyopathy V: Interprofessional Care
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction